| Witters L, Scherle P, Friedman S, et al.
Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor. [Journal Article, Research Support, Non-U.S. Gov't]
Cancer Res 2008 Sep 1; 68(17):7083-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Dawood S, Resetkova E, Gonzalez-Angulo AM
Trastuzumab Administration Associated with Change in HER2 Status. [JOURNAL ARTICLE]
Clin Breast Cancer 2008 Aug 1; 8(4):366-369.
Abstract | Full Citation | Find Related Articles | | Jahanzeb M
Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer. [JOURNAL ARTICLE]
Clin Breast Cancer 2008 Aug 1; 8(4):324-333.
Abstract | Full Citation | | Sugarman S, Wasserheit C, Hodgman E, et al.
A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma. [JOURNAL ARTICLE]
Breast Cancer Res Treat 2008 Aug 27.
Abstract | Full Citation | Find Related Articles | | Giannopoulou E, Antonacopoulou A, Floratou K, et al.
Dual targeting of EGFR and HER-2 in colon cancer cell lines. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2008 Aug 27.
Abstract | Full Citation | Find Related Articles | | Sherrill B, Amonkar MM, Stein S, et al.
Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Cancer 2008 Sep 2; 99(5):711-5.
Abstract | Full Citation | Find Related Articles | | De Rossi C, Brunello A, Jirillo G, et al.
When an Interim Analysis of Randomized Trial Changes the Practice in Oncology: The Lesson of Adjuvant Trastuzumab and the Hera Trial. [JOURNAL ARTICLE]
Immunopharmacol Immunotoxicol 2008 Aug 26.:1-4.
Abstract | Full Citation | Find Related Articles | | She QB, Chandarlapaty S, Ye Q, et al.
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
PLoS ONE 2008; 3(8):e3065.
Abstract | Full Citation | Find Related Articles | | Perez EA, Suman VJ
Lack of publication bias related to results from trastuzumab study. [Comment, Letter]
Lancet 2008 Aug 23; 372(9639):626-7.
Full Citation | Publisher Full Text | Find Related Articles | | Sabbah M, Emami S, Redeuilh G, et al.
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. [JOURNAL ARTICLE]
Drug Resist Updat 2008 Aug 19.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
